These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 14108533)

  • 1. [THERAPEUTIC RESULTS WITH THE USE OF SOME NEW ANABOLIC STEROID HORMONES].
    DOLECEK R; KLABUSAY L; HERZIG P
    Cas Lek Cesk; 1963 Oct; 102():1148-54. PubMed ID: 14108533
    [No Abstract]   [Full Text] [Related]  

  • 2. METHANDROSTENOLONE, AN ORAL ANABOLIC AGENT.
    JUNGCK EC; GREENBLATT RB
    South Med J; 1964 Aug; 57():909-13. PubMed ID: 14173048
    [No Abstract]   [Full Text] [Related]  

  • 3. [EXPERIENCES WITH THE ANABOLIC STEROID METHANDROSTENOLONE].
    KRONIG OJ; DEKKERS HJ; van der PLAATS AB; VAN LOOKERENCAMPAGNE
    Geneeskd Gids; 1964 Mar; 42():116-23. PubMed ID: 14145741
    [No Abstract]   [Full Text] [Related]  

  • 4. ANABOLIC STEROIDS: THEIR CLINICAL USE AND SPECIFIC DANGERS IN PEDIATRICS.
    LARON Z; GITTER S
    Clin Pediatr (Phila); 1963 Nov; 2():594-600. PubMed ID: 14085300
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on anabolic agents. I. Comparative study of the anabolic action of methandrostenolone (MA) and of 19-nortestosterone phenylpropionate (NTP) in the same individuals. II. Anabolic action of a depot form of methandrostenolone].
    de SALCEDO ; SOUSA CG
    J Med (Oporto); 1962 Apr; 47():979-82. PubMed ID: 14496307
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of negative nitrogen balance by an anabolic agent (methandrostenolone) during corticosteroid therapy (dexamethasone) in rheumatoid arthritis.
    RUCHELMAN H; FORD RV
    Metabolism; 1962 May; 11():524-9. PubMed ID: 14494977
    [No Abstract]   [Full Text] [Related]  

  • 7. Neurotoxic properties of the anabolic androgenic steroids nandrolone and methandrostenolone in primary neuronal cultures.
    Caraci F; Pistarà V; Corsaro A; Tomasello F; Giuffrida ML; Sortino MA; Nicoletti F; Copani A
    J Neurosci Res; 2011 Apr; 89(4):592-600. PubMed ID: 21290409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [USE OF ANABOLIC HORMONES (NEROBOL, NEROBOLIL) IN THE TREATMENT OF TUBERCULOSIS].
    BEDE L; LAKATOS M; LEVENDEL L
    Tuberk Tudobetegsegek; 1963 Dec; 16():377-8. PubMed ID: 14189505
    [No Abstract]   [Full Text] [Related]  

  • 9. TREATMENT OF MUSCULAR DYSTROPHY.
    WALTON JN
    Dev Med Child Neurol; 1964 Apr; 6():194-5. PubMed ID: 14141744
    [No Abstract]   [Full Text] [Related]  

  • 10. [ANABOLICS IN THE TREATMENT OF PULMONARY TUBERCULOSIS].
    MOLINA A; SPRINSKY P; GILMARINO A; CENEDESE JJ
    Arch Argent Tisiol Neumonol; 1963; 39():31-5. PubMed ID: 14067526
    [No Abstract]   [Full Text] [Related]  

  • 11. [THE METABOLIC EFFECT OF ANABOLIC STEROIDS AND THEIR CLINICAL APPLICATION].
    YOSHITOSHI Y
    Nihon Naibunpi Gakkai Zasshi; 1964 Dec; 40():1155-65. PubMed ID: 14267839
    [No Abstract]   [Full Text] [Related]  

  • 12. STUDIES ON THE NITROGEN BALANCE IN THE HUMAN DURING LONG-TERM TREATMENT WITH DIFFERENT ANABOLIC AGENTS UNDER STRICTLY STANDARDIZED CONDITIONS.
    SAARNE A; BJERSTAF L; EKMAN B
    Acta Med Scand; 1965 Feb; 177():199-211. PubMed ID: 14279501
    [No Abstract]   [Full Text] [Related]  

  • 13. [CLINICAL EXPERIMENTATION OF A PREPARATION FOR TOPICAL USE CONTAINING AN ANABOLIZING STEROID, METHANDROSTENOLONE, IN THE TREATMENT OF CUTANEOUS ULCERATIONS].
    GIACOMETTI F
    Rass Dermatol Sifilogr; 1964; 17():41-54. PubMed ID: 14141267
    [No Abstract]   [Full Text] [Related]  

  • 14. Dilated cardiomyopathy and acute liver injury associated with combined use of ephedra, gamma-hydroxybutyrate, and anabolic steroids.
    Clark BM; Schofield RS
    Pharmacotherapy; 2005 May; 25(5):756-61. PubMed ID: 15899737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [RECENT INFORMATION ON THE THERAPY OF BLOOD DISEASES].
    HASEGAWA Y; TSUKADA R
    Chiryo; 1964; 46():501-9. PubMed ID: 14126913
    [No Abstract]   [Full Text] [Related]  

  • 16. HYDROXYPROLINE EXCRETION IN ENDOCRINE DISEASE.
    BENOIT FL; THEIL GB; WATTEN RH
    Metabolism; 1963 Dec; 12():1072-82. PubMed ID: 14100279
    [No Abstract]   [Full Text] [Related]  

  • 17. MANAGEMENT OF RETARDED GROWTH WITH ANABOLIC STEROIDS.
    GOTH E
    Ther Hung; 1964; 12():140-3. PubMed ID: 14258786
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of hypoplastic anemias with protein anabolic steroids].
    Vlassembrouck M; Lederer J
    Rev Fr Endocrinol Clin; 1966; 7(5):389-96. PubMed ID: 5971593
    [No Abstract]   [Full Text] [Related]  

  • 19. [The therapeutic value of anabolic steroids in gastroenterology].
    Demole M
    Schweiz Med Wochenschr; 1966 Mar; 96(9):291-6. PubMed ID: 5983996
    [No Abstract]   [Full Text] [Related]  

  • 20. On the problem of gastric ulcer formation by glucocorticoids in rats and the effect of androgenic-anabolic steroid on them.
    Linèt O; Mikulásková J
    Endokrinologie; 1967 May; 51(3):224-33. PubMed ID: 5300289
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.